Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Clinical and Translational Oncology
Erschienen in:

11.08.2023 | REVIEW ARTICLE

Nephrectomy and IVC thrombectomy in renal cancer: a narrative review

verfasst von: Ali Faegh, Aysan Moeinafshar, Nima Rezaei

Erschienen in: Clinical and Translational Oncology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Renal cell carcinoma accounts for two to three percent of adult malignancies and can lead to inferior vena cava (IVC) thrombosis. This condition can decrease the rate of 5-year survival for patients to 60%. The treatment of choice in such cases is radical nephrectomy and inferior vena cava thrombectomy. This surgery is one of the most challenging due to many perioperative complications. There are many controversial methods reported in the literature. Achieving the free of tumor IVC wall and the possibility of thrombectomy in cases of level III and level IV IVC thrombosis are two essential matters previously advocated open approaches. Nevertheless, open approaches are being replaced by minimally invasive techniques despite the difficulty of the surgical management of IVC thrombectomy. This paper aims to review recent evidence about new surgical methods and a comparison of open, laparoscopic, and robotic approaches. In this review, we present the latest surgical strategies for IVC thrombectomy and compare open and minimally invasive approaches to achieve the optimal surgical technique. Due to the different anatomy of the left and right kidneys and variable extension of venous thrombosis, we investigate surgical methods for left and right kidney cancer and each level of IVC venous thrombosis separately.
Literatur
1.
Ma S, Jia W, Hou G, Quan P, Zhang L, Fan X, et al. Case reports of robot-assisted laparoscopic radical nephrectomy and inferior vena cava tumor thrombectomy. Medicine. 2021;100:e26886.PubMedPubMedCentralCrossRef
2.
Velasquez MC, Mouzannar ALI, Swain S, Ciancio G. Rarely described renal malignancies associated with venous tumor thrombus. Anticancer Res. 2022;42:1351–8.PubMedCrossRef
3.
Marshall FF, Dietrick DD, Baumgartner WA, Reitz BA. Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins. J Urol. 1988;139:1166–71.PubMedCrossRef
4.
Abel EJ, Carrasco A, Karam J, Tamboli P, Delacroix S, Vaporciyan AA, et al. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus. BJU Int. 2014;114:667–73.PubMedCrossRef
5.
Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94:33–41.PubMedCrossRef
6.
7.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, et al. European Association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75:799–810.PubMedCrossRef
8.
9.
10.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. JNCI J Natl Cancer Inst. 2006;98:1331–4.PubMedCrossRef
11.
Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34:193–205.PubMedCrossRef
12.
Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. The Lancet. 2009;373:1119–32.CrossRef
13.
Bigot P, Barthelemy P, Boissier R, Khene Z-E, Pettenati C, Bernhard J-C, et al. French AFU Cancer Committee Guidelines—update 2022–2024: management of kidney cancer. Prog Urol. 2022;32:1195–274.PubMedCrossRef
14.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMedCrossRef
15.
Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17:245–61.PubMedCrossRef
16.
Mendhiratta N, Muraki P, Sisk AE, Shuch B. Papillary renal cell carcinoma: review. Urol Oncol Semin Orig Investig. 2021;39:327–37.
17.
Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L. Comprehensive review of chromophobe renal cell carcinoma. Crit Rev Oncol Hematol. 2021;160: 103287.PubMedCrossRef
18.
19.
20.
Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. Giornale Italiano di Nefrologia. 2022;39(3):2022-vol3.
21.
Novacescu D, Feciche BO, Cumpanas AA, Bardan R, Rusmir AV, Bitar YA, et al. Contemporary clinical definitions, differential diagnosis, and novel predictive tools for renal cell carcinoma. Biomedicines. 2022;10:2926.PubMedPubMedCentralCrossRef
22.
Alam R, Patel HD, Osumah T, Srivastava A, Gorin MA, Johnson MH, et al. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study. BJU Int. 2019;123:42–50.PubMedCrossRef
23.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178:41–6.PubMedCrossRef
24.
Sidana A, Goyal J, Aggarwal P, Verma P, Rodriguez R. Determinants of outcomes after resection of renal cell carcinoma with venous involvement. Int Urol Nephrol. 2012;44:1671–9.PubMedCrossRef
25.
Bhindi B, Abel EJ, Albiges L, Bensalah K, Boorjian SA, Daneshmand S, et al. Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma. Eur Urol. 2019;75:111–28.PubMedCrossRef
26.
Fontana F, Deho F, Piacentino F, Curti M, Capogrosso P, Coppola A, et al. Management of renal cell carcinoma with extensive caval thrombosis utilizing a temporary atrial caval filter through a combined endovascular and open surgical technique. Vasc Endovascular Surg. 2021;55:505–9.PubMedCrossRef
27.
Lawindy SM, Kurian T, Kim T, Mangar D, Armstrong PA, Alsina AE, et al. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int. 2012;110:926–39.PubMedCrossRef
28.
Jurado A, Romeo A, Gueglio G, Marchiñena PG. Current trends in management of renal cell carcinoma with venous thrombus extension. Curr Urol Rep. 2021;22:23.PubMedCrossRef
29.
Liu Z, Zhang Q, Zhao X, Zhu G, Tang S, Hong P, et al. Inferior vena cava interruption in renal cell carcinoma with tumor thrombus: surgical strategy and perioperative results. BMC Surg. 2021;21:402.PubMedPubMedCentralCrossRef
30.
Kaptein FHJ, van der Hulle T, Braken SJE, van Gennep EJ, Buijs JT, Burgmans MC, et al. Prevalence, treatment, and prognosis of tumor thrombi in renal cell carcinoma. JACC CardioOncol. 2022;4:522–31.PubMedPubMedCentralCrossRef
31.
Duda A, Hanak C, Wirtz P, Lipscomb A, Mitiek M. Single-stage resection with intraoperative filter placement for right renal carcinoma with vena cava extension. J Vasc Surg Cases Innov Tech. 2021;7:691–3.PubMedPubMedCentralCrossRef
32.
Woodruff DY, van Veldhuizen P, Muehlebach G, Johnson P, Williamson T, Holzbeierlein JM. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol Semin Orig Investig. 2013;31:517–21.
33.
Ghoreifi A, Djaladat H. Surgical tips for inferior vena cava thrombectomy. Curr Urol Rep. 2020;21:51.PubMedCrossRef
34.
Adams LC, Ralla B, Bender Y-NY, Bressem K, Hamm B, Busch J, et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging. 2018;18:17.PubMedPubMedCentralCrossRef
35.
Toprak U, Erdoğan A, Gülbay M, Karademir MA, Paşaoğlu E, Akar OE. Pre-operative evaluation of renal anatomy and renal masses with helical CT, 3D-CT and 3D-CT angiography. Diagn Interv Radiol. 2005;11:35–40.PubMed
36.
Ciancio G. Inferior vena cava reconstruction using a ringed polytetrafluoroethylene interposition graft and inferior vena cava filter placement following resection of renal cell carcinoma with a tumor thrombus directly infiltrating the inferior vena cava. Vasc Endovasc Surg. 2022;56:5–10.CrossRef
37.
Salsano G, Palermo B, Barattini M, Puccianti F, Gentilli S, Romano N, et al. Pre-operative renal artery embolization in laparoscopic radical and partial nephrectomy: a multidisciplinary approach to renal tumors. Surg Technol Int. 2020;36:23–8.PubMed
38.
Zhuo L, Guodong Z, Xun Z, Shiying T, Peng H, Li Z, et al. A modified surgical technique of shortening renal ischemia time in left renal cancer patients with Mayo level II-IV tumor thrombus. BMC Surg. 2020;20:120.PubMedPubMedCentralCrossRef
39.
Morris PD, Furtado R, Pulitano C, Crawford M, Yeo D, Vasilaras A, et al. Inferior vena cava resection and reconstruction with bovine pericardium for renal cell carcinoma: complications and outcomes. Urology. 2019;134:143–7.PubMedCrossRef
40.
Hua Y-B, Li X, Wang D-X. Prevalence and risk factors of myocardial and acute kidney injury following radical nephrectomy with vena cava thrombectomy: a retrospective cohort study. BMC Anesthesiol. 2021;21:243.PubMedPubMedCentralCrossRef
41.
Novick AC, Kaye MC, Cosgrove DM, Angermeier K, Pontes JE, Montie JE, et al. Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg. 1990;212:472–7.PubMedPubMedCentralCrossRef
42.
Kalapara AA, Frydenberg M. The role of open radical nephrectomy in contemporary management of renal cell carcinoma. Transl Androl Urol. 2020;9:3123–39.PubMedPubMedCentralCrossRef
43.
Joseph S, Stuart H, Glenn P, Roger D. Surgical approaches for open renal surgery, including open radical nephrectomy. Hinman’s Atlas of urologic surgery. 4th ed. Philadelphia: Elsevier; 2019. p. 61–75.
44.
Kishore TA, Pathrose G, Raveendran V, Ganpule A, Gautam G, Laddha A, et al. Robot-assisted laparoscopic radical nephrectomy and inferior vena cava thrombectomy: a multicentre Indian experience. Arab J Urol. 2020;18:124–8.PubMedPubMedCentralCrossRef
45.
Pulford C, Keating K, Rohloff M, Peifer D, Eames R, Shakuri-Rad J, et al. Robotic-assisted nephrectomy with level II IVC thrombectomy using Rummel Tourniquets. Int Braz J Urol. 2022;48:196–7.PubMedCrossRef
46.
Chopra S, Simone G, Metcalfe C, de Castro Abreu AL, Nabhani J, Ferriero M, et al. Robot-assisted level II–III inferior vena cava tumor thrombectomy: step-by-step technique and 1-year outcomes. Eur Urol. 2017;72:267–74.PubMedCrossRef
47.
Metcalfe C, Chang-Kit L, Dumitru I, MacDonald S, Black P. Antegrade balloon occlusion of inferior vena cava during thrombectomy for renal cell carcinoma. Can Urol Assoc J. 2013;4:105.CrossRef
48.
Crisan N, Andras I, Grad D-L, Telecan T, Coman R-T, de Cobelli O, et al. Dual combined laparoscopic approach for renal-cell carcinoma with renal vein and level I–II inferior vena cava thrombus: our technique and initial results. J Endourol. 2018;32:837–42.PubMedCrossRef
49.
Swierzewski DJ, Swierzewski MJ, Libertino JA. Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension. Am J Surg. 1994;168:205–9.PubMedCrossRef
50.
Ciancio G, Shirodkar SP, Soloway MS, Salerno TA. Techniques for avoidance of sternotomy and cardiopulmonary bypass during resection of extensive renal cell carcinoma with vena caval tumor thrombus extension above the diaphragm. J Card Surg. 2009;24:657–60.PubMedCrossRef
51.
Bokka S, Manikandan R, Dorairajan LN, Srivathsa K, Sreenivasan Sreerag K, Kalra S, et al. Perioperative and oncological outcomes of renal cell carcinoma with venous tumour thrombus. Urol J. 2022;89:31–7.CrossRef
52.
Shuch B, Crispen PL, Leibovich BC, LaRochelle JC, Pouliot F, Pantuck AJ, et al. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011;107:724–8.PubMedCrossRef
53.
Marshall FF, Reitz BA, Diamond DA. A new technique for management of renal cell carcinoma involving the right atrium: hypothermia and cardiac arrest. J Urol. 1984;131:103–7.PubMedCrossRef
54.
Pouliot F, Shuch B, LaRochelle JC, Pantuck A, Belldegrun AS. Contemporary management of renal tumors with venous tumor thrombus. J Urol. 2010;184:833–41.PubMedCrossRef
55.
Sood A, Jeong W, Barod R, Bahnson E, Kirura P, Abdollah F, et al. Robot-assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: an IDEAL stage 0 study. J Surg Oncol. 2015;112:741–5.PubMedCrossRef
56.
Wang B, Huang Q, Liu K, Fan Y, Peng C, Gu L, et al. Robot-assisted level III–IV inferior vena cava thrombectomy: initial series with step-by-step procedures and 1-year outcomes. Eur Urol. 2020;78:77–86.PubMedCrossRef
57.
Kundavaram C, de Castro Abreu AL, Chopra S, Simone G, Sotelo R, Aron M, et al. Advances in robotic vena cava tumor thrombectomy: intracaval balloon occlusion, patch grafting, and vena cavoscopy. Eur Urol. 2016;70:884–90.PubMedCrossRef
58.
59.
Serag H, Featherstone JM, Griffiths DF, Mehta D, Dunne J, Hughes O, et al. Radical nephrectomy and intracaval thrombectomy for advanced renal cancer with extensive inferior vena cava involvement utilising cardiopulmonary bypass and hypothermic circulatory arrest: is it worthwhile? Arab J Urol. 2018;16:378–85.PubMedPubMedCentralCrossRef
60.
Liu Z, Zhao X, Ge L, Wu B, Tang S, Hong P, et al. Completely laparoscopic versus open radical nephrectomy and infrahepatic tumor thrombectomy: comparison of surgical complexity and prognosis. Asian J Surg. 2021;44:641–8.PubMedCrossRef
61.
Shao P, Li J, Qin C, Lv Q, Ju X, Li P, et al. Laparoscopic radical nephrectomy and inferior vena cava thrombectomy in the treatment of renal cell carcinoma. Eur Urol. 2015;68:115–22.PubMedCrossRef
62.
Lue K, Russell CM, Fisher J, Kurian T, Agarwal G, Luchey A, et al. Predictors of post-operative complications in patients who undergo radical nephrectomy and IVC thrombectomy: a large contemporary tertiary center analysis. Clin Genitourin Cancer. 2016;14:89–95.PubMedCrossRef
63.
Ciancio G, Manoharan M, Katkoori D, De Los SR, Soloway MS. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. Eur Urol. 2010;57:667–72.PubMedCrossRef
64.
Tabbara MM, González J, Ciancio G. The surgical evolution of radical nephrectomy and tumor thrombectomy: a narrative review. Ann Transl Med. 2023;11:262–262.PubMedPubMedCentralCrossRef
65.
Bansal RK, Tu HYV, Drachenberg D, Shayegan B, Matsumoto E, Whelan JP, et al. Laparoscopic management of advanced renal cell carcinoma with renal vein and inferior vena cava thrombus. Urology. 2014;83:812–7.PubMedCrossRef
66.
Disanto V, Pansadoro V, Portoghese F, Scalese GA, Romano M. Retroperitoneal laparoscopic radical nephrectomy for renal cell carcinoma with infrahepatic vena caval thrombus. Eur Urol. 2005;47:352–6.PubMedCrossRef
67.
Gu L, Ma X, Gao Y, Li H, Li X, Chen L, et al. Robotic versus open level I–II inferior vena cava thrombectomy: a matched group comparative analysis. J Urol. 2017;198:1241–6.PubMedCrossRef
68.
Labbate C, Hatogai K, Werntz R, Stadler WM, Steinberg GD, Eggener S, et al. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy. J Immunother Cancer. 2019;7:66.PubMedPubMedCentralCrossRef
Metadaten
Titel
Nephrectomy and IVC thrombectomy in renal cancer: a narrative review
verfasst von
Ali Faegh
Aysan Moeinafshar
Nima Rezaei
Publikationsdatum
11.08.2023
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 3/2024
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-023-03302-6

Weitere Artikel der Ausgabe 3/2024

Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer

  • RESEARCH ARTICLE

MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis

  • RESEARCH ARTICLE

LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma

  • RESEARCH ARTICLE

Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

  • RESEARCH ARTICLE

Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey

  • RESEARCH ARTICLE

Development of fatty acid metabolism score based on gene signature for predicting prognosis and immunotherapy response in colon cancer

  • RESEARCH ARTICLE

Neu im Fachgebiet Onkologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise